TOBI helps fight Pseudomonas aeruginosa in the lungs of people with CF
Pseudomonas aeruginosa infection is a major cause of decreased lung function in people with CF. TOBI is made specifically to treat Pseudomonas aeruginosa in the lungs.
When taken with the FDA-approved nebulizer and compressor, TOBI:
Is concentrated in the airways
Targets Pseudomonas aeruginosa in the lungs
Helps decrease the amount of Pseudomonas aeruginosa in the sputum
This can help manage Pseudomonas aeruginosa and improve lung function.
If your doctor prescribes TOBI, it's important to continue taking it as prescribed by your doctor, even if you feel healthy.